uniQure N.V. Ordinary Shares vs Rollins Inc. Common Stock — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while Rollins Inc. Common Stock trades at $32.61 (market cap $15.47B). The key difference: Rollins Inc. Common Stock is far larger — about 10.5× uniQure N.V. Ordinary Shares's market cap, and Rollins Inc. Common Stock pays a 2.27% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Rollins Inc. Common Stock for 0 Days on average.
| QURE | ROL | |
|---|---|---|
Market Cap | $1.48B | $15.47B |
Volume | 2,488,780 | 6,712,154 |
Sector | Health | Industrials |
52-Week High | $70.59 | $65.60 |
52-Week Low | $9.03 | $29.69 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $728.62M | $16.48B |
Dividend Yield | — | 2.27% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →